Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 14 of 100
Newsletters
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs
By
Sheryl Estrada
May 3, 2024
Health
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
By
Sunny Nagpaul
May 2, 2024
Finance
Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years
By
Will Daniel
May 1, 2024
Health
Superbugs could lower your life expectancy by nearly 2 years, report says. What to know about antimicrobial resistance
By
Lindsey Leake
April 26, 2024
Newsletters
AI for drug discovery draws a $1 billion launch—and a lot of hope
By
Sage Lazzaro
April 25, 2024
Leadership
Pharmaceutical giant Bayer’s manager cull will likely affect thousands of bosses—and the aspirin inventor thinks it will help its ‘brilliant’ Gen Z grads to thrive
By
Orianna Rosa Royle
April 24, 2024
Newsletters
How Moderna’s CIO helps steer the drugmaker’s post-COVID evolution
By
John Kell
April 17, 2024
Leadership
Pharmaceutical giant Bayer is getting rid of bosses and asking nearly 100,000 workers to ‘self-organize’ to save $2.15 billion
By
Orianna Rosa Royle
April 11, 2024
Success
Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO
By
Ryan Hogg
April 10, 2024
Health
Many cancer drugs remain unproven 5 years after accelerated approval, a study finds
By
Carla K. Johnson
and
The Associated Press
April 8, 2024
Health
ALS drug will be pulled from US market after study showed patients didn’t benefit
By
Matthew Perrone
and
The Associated Press
April 4, 2024
Commentary
It’s time for facts in the PBM debate
By
David Joyner
April 3, 2024
Newsletters
Johnson & Johnson CIO says employee upskilling is key to transforming health care
By
John Kell
April 3, 2024
Health
‘This is an emergency’: Trade group warns nearly a third of all independent pharmacies will go extinct because of a CMS rule
By
Maia Anderson
,
Healthcare Brew
and
Morning Brew
March 30, 2024
Retail
Walgreens’ frail quarter goes beyond the discretionary spending dips afflicting its competitors. It’s ‘just not very good at retailing,’ analyst says
By
Sasha Rogelberg
March 29, 2024
Most Popular
North America
'I meant what I said in Davos': Carney says he really is planning a Canada split with the U.S. along with 12 new trade...
By
Rob Gillies
and
The Associated Press
C-Suite
Coins2Day 500 CEOs are no longer giving employees an A for effort. Now they want proof of impact
By
Claire Zillman
Politics
The American taxpayer spent nearly half a billion dollars deploying federal troops to U.S. cities in 2025, CBO finds
By
Nick Lichtenberg